Smoking Behavior

3

Review clinical trials related to Smoking Behavior. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial

The purpose of this research study is to learn more about how Dialectical Behavior Therapy - Skills Training can help patients with cancer who smoke cigarettes cut down on or stop their smoking.

Participants needed: 16
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: May 26, 2026Locations: 2
Eligibility criteria

Smoke ≥1 cigarettes every day in the past 30 days per participant report. [+6]

Patients actively receiving external tobacco use counseling or using tobacco ces... [+4]

Status: Recruiting

Communicating About Nicotine Reduction in Cigarettes

The goal of this clinical trial is to learn how a messaging campaign about reduced nicotine cigarettes and policy, combined with the use of very low nicotine cigarettes (VLNCs), affects smoking behavior and attitudes among adult smokers. The study also aims to assess the efficacy of the messages in different populations, including smokers with past-month serious psychological distress (SPD), low socioeconomic status (SES), and those in neither category. The primary hypothesis is: exposure to messages in combination with VLNC use will lead to less cigarettes use compared to VLNCs without messages. Researchers will compare: The effects of receiving VLNCs with messages (treatment group) to receiving VLNCs without messages (control group). Participants will: Complete a baseline survey and be randomly assigned to one of two groups: treatment (VLNCs + messages) or control (VLNCs only). Attend weekly study visits for surveys, breath samples, and receive supply of VLNCs , either with or without the messaging campaign. Complete brief daily surveys through text messages.

Participants needed: 1,230
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Georgia State UniversityUpdated: Oct 29, 2025Locations: 2
Eligibility criteria

Age 21+ years [+4]

Pregnancy or lactation [+2]

Status: Not yet recruiting

HISTOLOGICAL RESULTS IN TRANSGENDER INDIVIDUALS ASSIGNED TO FEMALES AT BIRTH UNDERGOING GENDER AFFIRMATION SURGERY AND IN TESTOSTERONE THERAPY

The aim of this study is to report histological results of genital organs removed during gender affirmg surgery in transgender people assigned female at birth (AFAB), to increase the knowledge about the long-term effects of gender affirming hormone therapy with testosterone on these organs and to evaluate the incidence of benign and malign gynecological pathology in AFAB transgender people.

Participants needed: 100
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: IRCCS Azienda Ospedaliero-Universitaria di BolognaUpdated: Nov 29, 2024Locations: 1
Eligibility criteria

gender incongruence diagnosis [+4]

previous gynecological surgery [+1]